Q8F987 Release factor glutamine methyltransferase MolNFT, Molecular NFT on GenesisL1

Release factor glutamine methyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeigxepakyxurhuzjqxhjeqi2dmx7guwlqsloai6z7gvocym2eyig3u/metadata.json

IPFS of structure file:

bafybeihz7wrhd6ppoeqs377ew77tftubi6iww5wlydmvxnf27idf7e375e/AF-Q8F987-F1-model_v2.pdb

First NFT owner address (eip-55):

0x02df3F8069b24076E54c06706a40f151233Ec8EE

First NFT owner address (bech32):

genesis1qt0nlqrfkfq8de2vqecx5s832y3naj8wlcdvyv

Current NFT ID #309522 owner (web3):

0x7eb842fA4E2f66d9688D7097939A92e88C4855b6

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
309522
Accession (UniProt):
Q8F987
Name::
Release factor glutamine methyltransferase
Experimental Method:
Predicted structure
Sequence source:
Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8F987 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8F987|PRMC_LEPIN Release factor glutamine methyltransferase OS=Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601) OX=189518 GN=prmC PE=3 SV=1 MQHPDSILTLLKKSEEFLKKKEIPSARLDAEILLADLLNLQRVKLYVNFERLLNETEKNAYRERILERSKNKPTAYITSQKAFYNSIFFVNENVLIPRPETEELVEKVLSDFKGNIGEQNVLDLCTGSGCIGISLKLARKDWNITLSDISKEALEVATKNAIQILGEEKHIQFLESDLFLSIPKESKFNLIVTNPPYIPISDKAEMMKDVIDYEPHLALFLENPKDFLSTLIAQAYERLVEGGKLYMEILPSLSETIISDSIAKGWENGKIEKDLSGKERFVILTR

Q8F987 AF NFT

MOLNFT AF v1

NFT data

MOLNFT Q8F987 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience